Ethical and Regulatory CRISPR Quagmire in the US

Julia Franz and Katie Hiler, WUNC Science Friday, 27 August 2017,

Despite the results of August’s CRISPR edited embryo paper being called into question, its publication has resulted in an increase in the ethics debate.  Scientists agree that CRISPR gene editing will continue to improve and society must grapple with the ethical problems.  Ira Flatow sits down with the author of the August Nature article and with Kelly Ormond, genetics professor at Stanford University and member of the Stanford Center for Biomedical Ethics, to discuss the results and how to proceed.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply